Zyla Life Sciences (FKA Egalet Corporation)
Registrant's name change from Egalet Corporation to Zyla Life Sciences
Based in PA
🤖
AI Overview
With $515K in lobbying spend across 9 quarterly filings, Zyla Life Sciences (FKA Egalet Corporation) is an active lobbying client. Their lobbying covers 3 issue areas. Active from 2018 to 2019.
$515K
Total Spend
2
Years Active
1
Firms Hired
2
Lobbyists Deployed
3
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $515K |
| 2019 | $0 |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid, Health Issues, Alcohol & Drug Abuse
- •Prescription drug abuse policy issues
- •Provisions related to abuse-deterrent opioid formulary placement
- •Provisions related to abuse-deterrent opioid coverage and access in Medicare
- •S. 524 (114th Congress): Provisions related to opioid treatment and abuse
- •Prescription drug abuse policy issues
- •Provisions related to abuse-deterrent opioid formulary placement
- •Provisions related to abuse-deterrent opioid coverage and access in Medicare
- •H.R. 5582, the Abuse
Related Analysis
Related Investigations
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Healthcare's $3 Billion Bet
The healthcare industry's massive lobbying investment.
Federal Lobbying Statistics 2025
The definitive stats — $37.7B total, industry breakdowns, and trends.
What Is Lobbying? A Complete Guide
How lobbying works, who does it, and why it matters.
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.